MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 340 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $16,521,000 | -31.6% | 273,983 | -47.9% | 1.25% | -33.4% |
Q1 2016 | $24,161,000 | -2.0% | 525,462 | +3.1% | 1.88% | +36.7% |
Q4 2015 | $24,647,000 | +13.7% | 509,862 | 0.0% | 1.37% | +31.7% |
Q3 2015 | $21,669,000 | +5.2% | 509,862 | +182.8% | 1.04% | +13.9% |
Q2 2015 | $20,590,000 | -7.1% | 180,300 | +5.0% | 0.92% | -16.5% |
Q1 2015 | $22,161,000 | +37.9% | 171,700 | +6.4% | 1.10% | +16.2% |
Q4 2014 | $16,067,000 | +24.9% | 161,300 | +24.0% | 0.94% | -1.9% |
Q3 2014 | $12,863,000 | +35.8% | 130,100 | +5.9% | 0.96% | +36.3% |
Q2 2014 | $9,473,000 | – | 122,900 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |